Prime Medicine, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) (NCT07748403) | Prime Medicine, Inc. | 2026-08-01 |
| Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial (NCT07226622) | Prime Medicine, Inc. | 2025-12-29 |
| A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) (NCT06559176) | Prime Medicine, Inc. | 2024-10-17 |
Track Prime Medicine, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.